Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study highlights the importance of better face masks and good ventilation to mitigate COVID-19 indoors

A new study is highlighting a need for widespread use of better face masks and the importance of good ventilation to mitigate the spread of COVID-19 indoors.

19 Aug 2021

Experts recommend key steps to make re-opening of universities safer in autumn

Offering covid-19 vaccinations on campus, delayed or phased autumn re-openings, and mandatory face mask wearing are among the steps universities and colleges could take to make them safer places for students returning to, or starting, their studies this autumn, say public health experts in an opinion piece in The BMJ.

19 Aug 2021

Small study suggests a mix-and-match COVID-19 booster produces robust antibody levels

In a small study published in the medRxiv* preprint server, people given a booster Johnson & Johnson COVID-19 shot showed elevated and robust antibody levels.

19 Aug 2021

SARS-CoV-2 antibodies found to neutralize bat coronavirus (RaTG13) in new study

A striking new study examines how far antibodies elicited by vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or by natural infection, can neutralize the closely related bat coronavirus (CoV) RaTG13.

19 Aug 2021

How does the SARS-CoV-2 Delta variant’s spike drive membrane fusion and immunity evasion?

A fascinating and timely new study shows how the Delta variant of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) achieved higher transmissibility and resistance to neutralization.

19 Aug 2021

Durable highly protective T cell response to AAV-spike vaccine against COVID-19 pneumonia in mice

New research, available as a preprint on the bioRxiv* server, has focused on the role played by T cell immunity, particularly CD8+ cytotoxic T cells, on preventing lethal infection with SARS-CoV-2 in mice infused with peptide-loaded antigen-presenting dendritic cells (DCs).

19 Aug 2021

Did particulate matter from wildfires cause excess COVID-19 deaths in the US?

New research published in Science Advances investigates the relationship between wildfire smoke and COVID-19 mortality using pollution and COVID-19 incidence and mortality data.

19 Aug 2021

Early clinical trial data in for whole virus COVID-19 vaccine candidate

In a study uploaded to the preprint server medRxiv*, the efficacy of a whole virion Coronavirus vaccine was determined by giving the vaccine to healthy adult volunteers, which generated a robust immune response with evidence of T-cell activation.

19 Aug 2021

To stoke rural vaccination rates, trusted farmers are asked to spread word

When he became eligible for the coronavirus vaccine in Illinois, Tom Arnold, 68, said he didn’t need any convincing. He raises cattle, hogs and chickens in Elizabeth, a small town in the state's northwestern corner.

19 Aug 2021

If the unvaccinated want to work, they face a series of hurdles

With the delta variant surging, a growing number of employers are tiring of merely cajoling workers to get vaccinated against covid-19 and are following President Joe Biden's protocol for federal workers: Either show proof of vaccination, or mask up and get regular testing if you want to work on-site.

19 Aug 2021

Covid politics and fatigue work against contact-tracing foot soldiers

Health departments nationwide scaled back their contact tracing in late spring or early summer when covid-19 cases started to decrease as vaccination efforts took center stage.

19 Aug 2021

Phase I clinical study evaluates safety and pharmacokinetics of ExeVir's COVID-19 neutralizing antibody

ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, today announces that the first subjects have been dosed in a Phase I clinical study of XVR011, its llama-derived antibody for the treatment and prevention of COVID-19.

19 Aug 2021

Scientists identify a potent neutralizing nanobody against SARS-CoV-1

In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.

19 Aug 2021

White-tailed deer are highly susceptible to SARS-CoV-2 infection

The SARS-CoV-2 virus has been shown to infect a wide range of animals naturally and experimentally, and prior studies indicate deer are susceptible to infection. White-tailed deer (Odocoileus virginianus) fawns have been found to be susceptible to SARS-CoV-2.

19 Aug 2021

UT Health San Antonio professors urge uplifting US Latinos from obscurity to the forefront of health care

It is essential to lift the nation's Latino population from obscurity to the forefront of health care, public health intervention and societal presence, three professors from The University of Texas Health Science Center at San Antonio argue in a powerful commentary published Aug. 17 by the Journal of the American Medical Association.

19 Aug 2021

SARS-CoV-2 vaccine efficacy is strongly correlated with antibody neutralization levels

All COVID-19 vaccines appear less effective when faced with variants such as Delta, according to a new medRxiv* study. However, the researchers suggest that booster shots may help improve immunity and protect against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

18 Aug 2021

CDC declares four new COVID high-risk travel destinations

The coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome (SARS-CoV-2), is far from over. As the cases continue to rise, countries grapple with controlling the viral spread. To date, over 209 million individuals have been infected with SARS-CoV-2, with more than 17 million cases recorded worldwide over the past 28 days.

18 Aug 2021

ASU study shows how the COVID-19 pandemic impacted people’s sleep

Sleep has become elusive for many as a result of the coronavirus pandemic, according to new research from Arizona State University's Edson College of Nursing and Health Innovation.

18 Aug 2021

Nearly 140,000 deaths prevented by early U.S. COVID-19 vaccine rollout, study finds

With COVID-19 cases again on the rise in the United States and around the world, vaccination campaigns continue to be of vital importance for a successful return to pre-pandemic life.

18 Aug 2021

Genomic surveillance is vital to combat COVID-19

Although the development and increasingly widespread availability of effective and safe vaccines provides the greatest hope for the future recovery from the increasingly devastating COVID-19 pandemic, genomic surveillance is emerging as a vital necessity to achieve effective mitigation and containment.

18 Aug 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study highlights the importance of better face masks and good ventilation to mitigate COVID-19 indoors

Experts recommend key steps to make re-opening of universities safer in autumn

Small study suggests a mix-and-match COVID-19 booster produces robust antibody levels

SARS-CoV-2 antibodies found to neutralize bat coronavirus (RaTG13) in new study

How does the SARS-CoV-2 Delta variant’s spike drive membrane fusion and immunity evasion?

Durable highly protective T cell response to AAV-spike vaccine against COVID-19 pneumonia in mice

Did particulate matter from wildfires cause excess COVID-19 deaths in the US?

Early clinical trial data in for whole virus COVID-19 vaccine candidate

To stoke rural vaccination rates, trusted farmers are asked to spread word

If the unvaccinated want to work, they face a series of hurdles

Covid politics and fatigue work against contact-tracing foot soldiers

Phase I clinical study evaluates safety and pharmacokinetics of ExeVir's COVID-19 neutralizing antibody

Scientists identify a potent neutralizing nanobody against SARS-CoV-1

White-tailed deer are highly susceptible to SARS-CoV-2 infection

UT Health San Antonio professors urge uplifting US Latinos from obscurity to the forefront of health care

SARS-CoV-2 vaccine efficacy is strongly correlated with antibody neutralization levels

CDC declares four new COVID high-risk travel destinations

ASU study shows how the COVID-19 pandemic impacted people’s sleep

Nearly 140,000 deaths prevented by early U.S. COVID-19 vaccine rollout, study finds

Genomic surveillance is vital to combat COVID-19

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in